Executive Appointment

Henderson – October 12, 2026 -- YMX Logistics has hired Adam Buttgenbach, a fleet executive who previously oversaw more than 110,000 assets globally, as Vice President of Fleet Strategy & Loss Prevention.

The appointment comes as the Henderson, Nevada-based yard logistics provider expands nationwide, according to Chief Operating Officer Erin Mitchell. She said fleet strategy and asset performance are critical to delivering safer, more efficient and more sustainable operations for enterprise customers.

Buttgenbach brings 20-plus years across logistics, procurement and maintenance

Buttgenbach has more than 20 years of leadership experience in logistics, procurement, maintenance and operational transformation. He has led large-scale fleet and equipment organizations with billion-dollar capital investment portfolios.

San Carlos, Calif. – October 12, 2026 -- Noah Medical has created a Chief Pulmonary Advisor role and filled it with Krish Bhadra, MD, an interventional pulmonologist at Stanford Medicine who has performed more than 2,300 robotic-assisted bronchoscopy procedures.

Bhadra to steer clinical education, evidence strategy and product development

In the newly created position, Bhadra will guide Noah Medical's clinical education, evidence strategy and product development. The medical robotics company said the aim is to expand access to advanced robotic bronchoscopy for the millions of patients at risk for lung cancer.

Noah Medical CEO Jian Zhang said the company is scaling the impact of its Galaxy System and called Bhadra "exactly the partner we need" for that effort.

Henderson, Nevada – October 12, 2026 -- YMX Logistics has appointed Michael Lucas as Chief Operating Officer, giving him responsibility for operational strategy and execution across the company's coast-to-coast yard logistics network.

Lucas brings leadership experience from four North American brands

Lucas has held supply chain and operations leadership roles at SC Johnson, The Kraft Heinz Company, Houghton Mifflin Harcourt (HMH) and Uline. His background covers distribution, warehousing, fleet operations, customer service and process improvement, including large-scale transformation programs.

Houston – October 12, 2026 -- MSC Income Fund (NYSE: MSIF) plans to hand the CEO role to Nicholas T. Meserve in the fourth quarter of 2026, while Dwayne L. Hyzak, Chairman and CEO since October 2020, stays on as Executive Chairman.

Hyzak to work alongside Meserve as Executive Chairman

Hyzak will work closely with Meserve in his Executive Chairman capacity. The Fund's board of directors designed the transition as part of its long-term succession plan. The timing is described as presently planned, so it remains subject to change.

Meserve has led private loan strategy since the Fund's inception

Meserve is a Managing Director of MSC Income and group head of its private credit investment team. He has held the Managing Director role since 2020. Earlier, he served on the Fund's Board from 2016 until 2020.

Toronto – October 12, 2026 -- Highlander Silver Corp. (TSX, NYSE American: HSLV) has appointed Poonam Puri as an independent director, effective immediately.

Puri brings tenured law and governance credentials from Osgoode Hall

Puri is a tenured Professor of Law and Research Chair in Corporate Governance at Osgoode Hall Law School in Toronto. She is also a corporate lawyer and Affiliated Scholar at Davies, Ward, Phillips & Vineberg, LLP. Her specialties are corporate law, corporate governance and capital markets regulation.

She is a member of the Order of Ontario. Her honors include the Institute of Corporate Directors Fellowship Award, the Ontario Law Society Medal and the Royal Society of Canada's Yvan Allaire Medal. She graduated from the University of Toronto Faculty of Law and Harvard Law School.

Dallas – October 12, 2026 -- Southwest Airlines Co. (NYSE: LUV) has appointed two sitting chief executives, Jason Liberty of Royal Caribbean Group and Varun Krishna of Rocket Companies, to its Board of Directors, effective immediately.

The Board said it chose directors with public company leadership experience and expertise in technology, digital innovation, commercial strategy and financial leadership. Southwest is executing its strategic priorities and aims to drive shareholder value.

Toronto – – October 12, 2026 -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) replaced its chief financial officer effective immediately, promoting Corporate Controller Matthew Sobczyk to Interim CFO after Rashed Dewan stepped down from the role.

Sobczyk, a 2020 hire, takes over the finance function

Sobczyk first joined the interventional MRI (iMRI) company in 2020 and moves up from Corporate Controller. The company did not name a permanent successor or give a timeline for a CFO search.

Dewan stays on a short-term consulting contract

Dewan will remain with Profound under a short-term consulting contract to support the handover. CEO and Chairman Arun Menawat thanked him for his years of service and his contributions to the company.

Toronto – October 12, 2026 -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) has appointed Richard Fabian, a medical imaging executive with more than 29 years of experience, as President, effective immediately, as the company moves its previous President into a newly created Chief Technology Officer role.

Fabian succeeds Mathieu Burtnyk, who becomes Chief Technology Officer

Fabian replaces Mathieu Burtnyk, PhD, who shifts to the newly created CTO position. Burtnyk invented the patented closed-loop temperature feedback control algorithm used by the TULSA-PRO platform. He has also led the scientific design and execution of all of the company's clinical studies for the technology, including the ongoing Level 1 post-market CAPTAIN randomized controlled trial.

Calgary – October 12, 2026 -- XORTX Therapeutics (NASDAQ: XRTX | TSXV: XRTX) has appointed Mika Grasso, 28, as co-CEO responsible for finance and public markets, and says it aims to advance its lead gout program, XRx-026, toward marketing approval over the next 18 months.

The company says the appointment follows a recent financing and growing investor interest. It is now restructuring its corporate and issuer status, re-initiating drug development programs and preparing regulatory filings for XRx-026. Risk disclosures in the release also refer to a voluntary delisting that may not be completed on the anticipated timeline, or at all.

Calgary – October 12, 2026 -- XORTX Therapeutics Inc. (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU) has appointed Depesh Narotam, a financial services executive with more than 20 years of experience, to its board as an independent director effective July 27, 2026.

Board determines Narotam meets Nasdaq and Canadian independence standards

The board determined that Narotam, 43, is independent under applicable Nasdaq listing standards and Canadian securities laws. He also joins the board's Compensation, Governance and Nominating Committee.

Narotam is a resident of British Columbia, Canada.